Hepatitis B vaccine guidance set to be rolled back for US babies: what the science says

2 min read Original article ↗

A panel of US vaccine advisers voted to rescind a recommendation that all newborns should receive a hepatitis B vaccine at birth.

By

  1. Mariana Lenharo

    1. Mariana Lenharo is a reporter for Nature in New York City.

  2. Heidi Ledford

    1. Heidi Ledford reports for Nature from Seattle, Washington.

Members of a top US vaccine advisory panel voted today to roll back a decades-old recommendation that all newborns receive a hepatitis B vaccine shortly after birth — a measure that has been associated with a sharp decline in mother-to-child transmission of the hepatitis B virus, which causes liver disease.

Updates & Corrections

  • Update 05 December 2025: This story was updated 5 December with the results of the vaccine panel’s vote.

References

  1. Abers, M. S., Ulrich, A. K. & Walensky, R. P. JAMA https://doi.org/10.1001/jama.2025.24996 (2025).

    Article  Google Scholar 

  2. Scheiblauer, H. et al. Vox Sang. 98, 403–414 (2010).

    Article  PubMed  Google Scholar 

  3. Pham, T. T. H. et al. Am. J. Prev. Med. 65, 52–59 (2023).

    Article  PubMed  Google Scholar 

  4. Bond, W. W. et al. Lancet 317, 550–551 (1981).

    Article  Google Scholar 

  5. Bixler, D., Barker, L., Lewis, K., Peretz, L. & Teshale, E. Hepatol. Commun. 7, e0118 (2023).

    Article  PubMed  Google Scholar 

Download references